Boston Scientific (NYSE: BSX) announced today that it agreed to acquire Axonics (Nasdaq:AXNX) in a deal worth approximately $3.7 billion. Shares of AXNX…
Boston Scientific to Purchase Axonics (AXNX) Medical Tech Firm for $3.7 Billion bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.
The deal gives Marlborough-based Boston Scientific access to a product portfolio that includes a device that delivers electrical stimulation to restore communication between the brain and the bladder.